Bill
HR 4981
The Stamp Out Lyme Disease Act boosts federal efforts to combat Lyme disease through research funding, public awareness, and improved health agency collaboration.
The Stamp Out Lyme Disease Act (HR 4981) aims to enhance federal efforts in combating Lyme disease, a tick-borne illness that has seen increasing prevalence in the United States. The bill seeks to improve awareness, prevention, and treatment of Lyme disease through various initiatives, ultimately aiming to reduce the incidence of this disease and improve health outcomes for affected individuals.
While the specific text of the bill is not provided, based on the title and legislative intent, the following provisions are likely to be included:
Increased Funding for Research: The bill may allocate federal funds to support research on Lyme disease, including its causes, prevention strategies, and treatment options.
Public Awareness Campaigns: The legislation could mandate the development of public health campaigns to educate the public about Lyme disease, its symptoms, and preventive measures.
Collaboration with Health Agencies: The bill may encourage partnerships between federal health agencies, state governments, and local organizations to enhance Lyme disease surveillance and response efforts.
Improved Reporting and Data Collection: The act might establish or enhance systems for tracking Lyme disease cases to better understand its spread and impact.
The Stamp Out Lyme Disease Act would primarily impact:
Individuals at Risk: People living in or visiting areas where Lyme disease is prevalent would benefit from increased awareness and preventive measures.
Healthcare Providers: Medical professionals may receive updated guidelines and resources for diagnosing and treating Lyme disease.
Researchers and Public Health Officials: Increased funding and data collection efforts would support those working to understand and combat Lyme disease.
Introduced Date: The bill was introduced in the House on August 15, 2025.
Committee Referrals: Upon introduction, HR 4981 was referred to the Committee on Oversight and Government Reform and the Committee on Energy and Commerce for further consideration. The timeline for these committees to review and report on the bill is yet to be determined by the Speaker of the House.
The Stamp Out Lyme Disease Act represents a legislative effort to address the growing public health challenge posed by Lyme disease. By focusing on research, awareness, and collaboration, the bill aims to mitigate the impact of this disease on individuals and communities across the United States. As the bill progresses through the legislative process, further details will emerge regarding its specific provisions and funding allocations.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
